logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Seminars in Hematology cover

Seminars in Hematology

IF4.1
Papers1434
Citations2435
Journal Papers 1474
Publication Date
delete
The Current State of Cerebral Complications of Sickle Cell Disease
deleteSeminars in Hematology
IF4.1
delete2026-08-09
delete0
PREAI
deleteDanielle Cicka; Tanatuch Tiratrakoonseree; Melanie E. Fields
deleteShare
deleteSave
Blood or Marrow Transplantation and Cellular Therapies in Myeloproliferative Neoplasms - A Comprehensive Review
deleteSeminars in Hematology
IF4.1
delete2026-07-31
delete0
PREAI
deleteKanishka Uttam Chandani; Tania Jain
deleteShare
deleteSave
Closing the Disease Modification Gap: Emerging Therapies in Myelofibrosis Beyond JAK Inhibition
deleteSeminars in Hematology
IF4.1
delete2026-07-30
delete0
deleteOAAI
deleteAkshay Aluri; Ashwin Kishtagari
deleteShare
deleteSave
The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting
deleteSeminars in Hematology
IF4.1
delete2026-07-17
delete0
PREAI
deleteKhaled Elhusseiny; Brandi N. Reeves
deleteShare
deleteSave
Germline predisposition in myeloproliferative neoplasms
deleteSeminars in Hematology
IF4.1
delete2026-07-03
delete0
PREAI
deleteMeytal Chernoff; Michael W. Drazer
deleteShare
deleteSave
Telomeres biology disorders: the past, the present and the future
deleteSeminars in Hematology
IF4.1
delete2026-06-09
delete0
PREAI
deleteEmma M. Groarke; Fernanda Gutierrez-Rodrigues
deleteShare
deleteSave
The many facets of cardiopulmonary complications in sickle cell disease
deleteSeminars in Hematology
IF4.1
delete2026-06-06
delete0
PREAI
deleteThomas d’Humières; Sylvain Le Jeune; Gonzalo de Luna; Thibaut Moulin; Laurent Boyer; Haytham Derbel; Sihem Iles; Nicolas Lellouche; Antonio Fiore; Geneviève Derumeaux; Pablo Bartolucci; Armand Mekontso Dessap; Laurent Savale
deleteShare
deleteSave
Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies
deleteSeminars in Hematology
IF4.1
delete2026-06-03
delete0
deleteOAAI
deleteLachelle D. Weeks
deleteShare
deleteSave
Pain in SCD—Many mechanisms and mysteries
deleteSeminars in Hematology
IF4.1
delete2026-06-01
delete0
PREAI
deleteOlufunke Y. Martin; Deepika S. Darbari
deleteShare
deleteSave
Minimal residual disease testing in hematologic malignancies: From early endpoint to precision clinical decision making
deleteSeminars in Hematology
IF4.1
delete2026-05-14
delete0
PREAI
deleteOla Landgren
deleteShare
deleteSave
Evolving Insights into Mitochondrial Presence in RBC in Sickle Cell Disease: Red Blood Cell and Reticulocyte Pathophysiology, Therapeutic Strategies, and Future Directions
deleteSeminars in Hematology
IF4.1
delete2026-05-09
delete0
PREAI
deleteYaw Ansong-Ansongton; Daisy Zapet Bamac; Angela Rivers
deleteShare
deleteSave
Cellular pathogenesis of HbSC disease
deleteSeminars in Hematology
IF4.1
delete2026-05-06
delete0
deleteOAAI
deleteJ.S. Gibson; R. Wadud; P. Ding; D.C. Rees; J.N. Brewin; K.M. Connolly
deleteShare
deleteSave
Telomere Biology Disorders and Hepatic Disease
deleteSeminars in Hematology
IF4.1
delete2026-05-02
delete0
PREAI
deleteSana A. Pirzada; Wesam Aleyadeh; Sawsan Fathma; Christopher Koh; Aurélie Plessier; David E. Kleiner; Theo Heller
deleteShare
deleteSave
Telomere Biology Disorders as an Example of Rare Disease Advocacy
deleteSeminars in Hematology
IF4.1
delete2026-04-23
delete0
PREAI
deleteKatie Barrett Stevens; Hannah A Raj; Jane K Paxton; Hilary J Longhurst
deleteShare
deleteSave
Current Landscape and Future Directions for Treatment of Accelerated-Phase and Blast-Phase Myeloproliferative Neoplasms
deleteSeminars in Hematology
IF4.1
delete2026-04-19
delete0
PREAI
deleteRohan K. Achar; Jan Philipp Bewersdorf
deleteShare
deleteSave
DIAGNOSIS AND MANAGEMENT OF TELOMERE BIOLOGY DISORDERS IN DEVELOPING COUNTRIES
deleteSeminars in Hematology
IF4.1
delete2026-04-19
delete0
deleteOAAI
deleteAlfredo Rodríguez; Brenda A. Avendaño-Robles; Marilia B. Catto; Rocío Juárez-Velázquez; Rodrigo T. Calado
deleteShare
deleteSave
Ten Years of Clinical Genetic Therapies for Sickle Cell Disease: Current and Future Directions
deleteSeminars in Hematology
IF4.1
delete2026-04-17
delete0
PREAI
deleteAlexis Leonard
deleteShare
deleteSave
More disease-modifying therapies for sickle cell disease: are small molecules and drug repurposing the way forward?
deleteSeminars in Hematology
IF4.1
delete2026-04-15
delete0
deleteOAAI
deleteCharles T. Quinn
deleteShare
deleteSave
Diagnosis and Management of Hematologic Malignancies in the Context of Telomere Biology Disorders
deleteSeminars in Hematology
IF4.1
delete2026-04-01
delete0
PREAI
deleteAlejandro Ferrer; Mrinal M. Patnaik
deleteShare
deleteSave
Role of MRD testing in acute myeloid leukemias. What is the status and how to get there?
deleteSeminars in Hematology
IF4.1
delete2026-03-20
delete0
PREAI
deleteChristopher S. Hourigan
deleteShare
deleteSave